SEARCH

SEARCH BY CITATION

References

  • ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 4858.
  • BAKER, L.P., NIELSEN, M.D., IMPEY, S., METCALF, M.A., POSER, S.W., CHAN, G., OBRIETAN, K., HAMBLIN, M.W. & STORM, D.R. (1998). Stimulation of type I and type 8 Ca2+ calmodulin-sensitive adenylyl cyclases by the GS-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J. Biol. Chem., 273, 1746917476.
  • BARD, J.A., ZGOMBICK, J., ADHAM, N., VAYSSE, P., BRANCHEK, T.A. & WEINSHANK, R.L. (1993). Cloning of a novel serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem., 31, 2342223426.
  • BOESS, F.G. & MARTIN, I.L. (1994). Review: molecular biology of 5-HT receptors. Neuropharmacol., 33, 275317.
  • BONHAUS, D.W., WEINHARDT, K.K., TAYLOR, M., DESOUZA, A., MCNEELEY, P.M., SZCZEPANSKI, K., FONTANA, D.J., TRINH, J., ROCHA, C.L., DAWSON, M.W., FLIPPIN, L.A. & EGLEN, R.M. (1997). RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacol., 36, 621629.
  • BRADFORD, M.M. (1976). A rapid sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248254.
  • CARTER, D., CHAMPNEY, M., HWANG, B. & EGLEN, R.M. (1995). Characterization of post-junctional 5-hydroxytryptamine (5-HT) receptor mediating relaxation of guinea-pig isolated ileum. Eur. J. Pharmacol., 280, 243250.
  • CASTRO, E.M., ROMÓN, T., CASTILLO, M.J., DEL OLMO, E., PAZOS, A. & DE ARCO, C. (1997). Identification and characterisation of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain. J. Neuropharmacol., 69, 21232131.
  • CHENG, Y.C. & PRUSOFF, W.H. (1973). Relationship between the inhibitor constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol., 22, 30993108.
  • CLOSSE, A. (1983). [3H]-Mesulergine, a selective ligand for serotonin-2 receptors. Life Sci., 32, 24852495.
  • CUSHING, D.J. & COHEN, M.L. (1992). Sertonin-induced relaxation in canine coronary artery smooth muscle. J. Pharmacol. Exp. Ther., 263, 123129.
  • DYER, S.M., BEXIS, S., MANE, M.T., DE LA LANDE, I.S., FREWIN, D.B. & HEAD, R.J. (1994). Interactions between 5-hydroxytryptamine, noradrenaline and the thromboxane-A(2) mimetic U44069 in the marmoset isolated aorta. Clin. Exp. Pharmacol. Physiol., 21, 201206.
  • EGLEN, R.M., JAKEMAN, L. & ALVAREZ, R.A. (1994). The 5-hydroxytryptamine7 receptor. Expert Opin. Invest. Drugs, 3, 175177.
  • EGLEN, R.M., JASPER, J.R., CHANG, D.J. & MARTIN, G.R. (1997). The 5-HT7 receptor: orphan found. Trends in Pharmacol. Sci., 18, 104107.
  • EHLERT, F.J. (1988). Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol., 33, 187194.
  • ERLANDER, M.G., LOVENBERG, T.W., BARON, B.M., DELECEA, L., DANIELSON, P.E., RACKE, M., SLONE, A.L., SIEGEL, B.W., FOYE, P.E., CANNON, K., BRUNS, J.E. & SUTCLIFFE, J.G. (1993). Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Natl. Acad. Sci. USA, 90, 34523457.
  • FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1984). 5-hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur. J. Pharmacol., 96, 7178.
  • FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Handbook of experimental pharmacology, catecholamines, Vol 33. (eds.) Blaschko, H. & Muscholl E. pp. 285335. New York: SpringerVerlag.
  • GUSTAFSON, E.L., DURKIN, M.M., BARD, J.A., ZGOMBICK, J. & BRANCHEK, T.A. (1996). A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Br. J. Pharmacol., 117, 657666.
  • HEIDMANN, D.E.A., METCALF, M.A., KOHEN, R. & HAMBLIN, M.W. (1997). Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron–exon organisation. J. Neurochem., 68, 13721381.
  • HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157204.
  • JAVID, F.A. & NAYLOR, R.J. (1997). Characterisation of the 5-HT receptors mediating the contractile effect of 5-HT in the terminal region of the rat small intestine. Br. J. Pharmacol., 112, 311P.
  • KALKMAN, H.O., ENGEL, G. & HOYER, D. (1986). Inhibition of 5-carboxamidotryptamine-induced relaxation of guinea-pig ileum correlates with [125l]LSD binding. Eur. J. Pharmacol., 129, 139145.
  • KENAKIN, T. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev., 36, 165222.
  • KITAZAWA, T., KUBO, O., SATOH, M. & TANEIKE, T. (1998). Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine. Br. J. Pharmacol., 123, 173182.
  • LANZAFAME, A., CHRISTOPOULOS, A. & MITCHELSON, F. (1996). Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors. Eur. J. Pharmacol., 316, 2732.
  • LOVENBERG, T.W., BARON, B., DE LECEA, L., MILLER, J.D., PROSSER, R.A., REA, M.A., FOYE, P.E., RACKE, M., SLONE, A.L., SIEGEL, B.W., DANIELSON, P.E., SUTCLIFFE, J.G. & ERLANDER, M.G. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron, 11, 449458.
  • LUCAS, J.J. & HEN, R. (1995). New players in the 5-HT receptor field: genes and knockouts. Trends in Pharmacol. Sci., 16, 246252.
  • MARTIN, G.R. & WILSON, R.J. (1995). Operational characteristics of a 5-HT receptor mediating direct vascular relaxation: identity with the 5-HT7 receptor Br. J. Pharmacol., 114, 383P.
  • McLEAN, P. & COUPAR, I.M. (1996). Characterisation of a postjunctional 5-ht7-like and a prejunctional 5-HT3 receptor mediating contraction of rat isolated jejunum. Eur. J. Pharmacol., 312, 215225.
  • MONSMA, F.J., SHEN, Y., WARD, R.P., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclin psychotropic drugs. Mol. Pharmacol., 43, 320327.
  • NAMBA, T., SUGIMOTO, Y., NEGISHI, M., IRIE, A., USHIKUBI, F., KAZIZUKA, A., ITO, I., ICHIKAWA, A. & NARUMIYA, S. (1993). Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature, 365, 166170.
  • PAZOS, A., HOYER, D. & PALACIOS, J.M. (1985). Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur. J. Pharmacol., 106, 531538.
  • PINKUS, L.M., SARBIN, N.S., GORDON, J.C. & MUNSON JR, H.R. (1990). Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers. Eur. J. Pharmacol., 179, 231235.
  • PLASSAT, J.L., AMLAIKY, N. & HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229236.
  • RINNE, U.K. (1983). New ergot derivatives in the treatment of Parkinson's disease. In: Lisuride and other dopamine agonists. (eds.). Caine, D.B. et al. pp. 431442. New York: Raven Press.
  • ROTH, B.L., CRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, F.J., SHEN, Y., MELTZER, H.Y. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 268, 14031410.
  • RUAT, M., TRAIFFORT, E., LEURS, R., TARDIVEL-LACOMBE, J., DIAZ, J., ARRANG, J.-M. & SCHWARTZ, J.-C. (1993). Molecular cloning, characterization, and localization of a high affinity serotonin receptor (5-HT7) activating cyclic AMP formation. Proc. Natl. Acad. Sci. USA, 90, 85478551.
  • SHEN, Y., MONSMA Jr, F.J., METCALF, M.A., JOSE, P.A., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem., 268, 1820018204.
  • SHENKER, A., MAAYANI, S., WEINSTEIN, H. & GREEN, J.P. (1987). Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea-pig hippocampal membranes. Mol. Pharmacol., 31, 357367.
  • SLEIGHT, A.J., BOESS, F.G., BOURSON, A., SIBLEY, D.R. & MONSMA JR, F.J. (1995b). 5-HT6 and 5-HT7 serotonin receptors: Molecular biology and pharmacology. Neurotransmissions, 11, 15.
  • SLEIGHT, A.J., CAROLO, C., PETIT, N., ZWINGELSTEIN, C. & BOURSON, A. (1995a). Identification of 5-Hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity of chronic antidepressant treatment. Mol. Pharmacol., 47, 99103.
  • SUMNER, M.J., FENIUK, W. & HUMPHREY, P.P.A. (1989). Further characterisation of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br. J. Pharmacol., 97, 292300.
  • SUNAHARA, R.K., DESSAUER, C.W. & GILMAN, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Ann. Rev. Pharmacol. Toxicol., 36, 461480.
  • TO, Z.P., BONHAUS, D.W., EGLEN, R.M. & JAKEMAN, L.B. (1995). Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br. J. Pharmacol., 115, 107116.
  • TSOU, A.P., KOSAKA, A., BACH, C., ZUPPAN, P., YEE, C., TOM, L., ALVAREZ, R., RAMSEY, S., BONHAUS, D.W., STEFANICH, E., JAKEMAN, L., EGLEN, R.M. & CHAN, H.W. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J. Neurochem., 63, 456464.
  • VANETTI, M., VOGT, G. & HOLLT, V. (1993). The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitisation. FEBS Lett., 331, 260266.
  • WAYMAN, G.A., IMPEY, S., WU, Z., KINDSVOGEL, W., PRICHARD, L. & STORM, D.R. (1994). Synergistic action of the type 1 adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo. J. Biol. Chem., 269, 2540025405.